Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $1.1 Million - $1.39 Million
4,100 Added 1366.67%
4,400 $1.2 Million
Q1 2024

May 15, 2024

SELL
$304.11 - $351.99 $516,987 - $598,383
-1,700 Reduced 85.0%
300 $103,000
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $538,740 - $730,080
2,000 New
2,000 $645,000
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $128,004 - $163,628
-400 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $351,703 - $411,620
-1,100 Reduced 73.33%
400 $148,000
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $1.98 Million - $2.24 Million
-6,500 Reduced 81.25%
1,500 $499,000
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $2.3 Million - $2.5 Million
8,000 New
8,000 $2.5 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.88B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.